From the Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY (B.C., S.H., Y.S., Y-J.W., A.H., A.B., N.G.F.).
Department of Developmental Biology, University of Texas Southwestern, Dallas (J.G.).
Circ Res. 2019 Jun 21;125(1):55-70. doi: 10.1161/CIRCRESAHA.119.315069. Epub 2019 May 16.
TGF (transforming growth factor)-β is critically involved in myocardial injury, repair, and fibrosis, activating both Smad (small mothers against decapentaplegic)-dependent and non-Smad pathways. The in vivo role of TGF-β signaling in regulation of macrophage function is poorly understood. We hypothesized that in the infarcted myocardium, activation of TGF-β/Smad signaling in macrophages may regulate repair and remodeling.
To investigate the role of macrophage-specific TGF-β Smad3 signaling in a mouse model of myocardial infarction and to dissect the mechanisms mediating Smad-dependent modulation of macrophage function.
TGF-βs markedly activated Smad3 in macrophages, without affecting Smad-independent pathways. Phagocytosis rapidly and directly activated macrophage Smad3, in the absence of active TGF-β release. MyS3KO (myeloid cell-specific Smad3 knockout) mice had no baseline defects but exhibited increased late mortality and accentuated dilative postmyocardial infarction remodeling. Adverse outcome in infarcted MyS3KO mice was associated with perturbations in phagocytic activity, defective transition of macrophages to an anti-inflammatory phenotype, scar expansion, and accentuated apoptosis of border zone cardiomyocytes. In vitro, Smad3 null macrophages exhibited reduced expression of genes associated with eat-me signals, such as Mfge8 (milk fat globule-epidermal growth factor factor 8), and reduced capacity to produce the anti-inflammatory mediators IL (interleukin)-10 and TGF-β1, and the angiogenic growth factor VEGF (vascular endothelial growth factor). Mfge8 partly rescued the phagocytic defect of Smad3 null macrophages, without affecting inflammatory activity. Impaired anti-inflammatory actions of Smad3 null macrophages were associated with marked attenuation of phagocytosis-induced PPAR (peroxisome proliferator-activated receptor) expression. MyS3KO mice had no significant alterations in microvascular density and interstitial fibrosis in remodeling myocardial segments.
We demonstrate that Smad3 critically regulates function of infarct macrophages, by mediating acquisition of a phagocytic phenotype and by contributing to anti-inflammatory transition. Smad3-dependent actions in macrophages protect the infarcted heart from adverse remodeling.
TGF-β(转化生长因子)β在心肌损伤、修复和纤维化中起着至关重要的作用,激活 Smad(小母亲对抗 decapentaplegic)依赖性和非 Smad 途径。TGF-β信号在调节巨噬细胞功能中的体内作用知之甚少。我们假设,在梗死的心肌中,巨噬细胞中 TGF-β/Smad 信号的激活可能调节修复和重塑。
研究巨噬细胞特异性 TGF-β Smad3 信号在心肌梗死小鼠模型中的作用,并剖析介导 Smad 依赖性调节巨噬细胞功能的机制。
TGF-βs 显著激活了巨噬细胞中的 Smad3,而不影响 Smad 非依赖性途径。吞噬作用迅速且直接激活了巨噬细胞中的 Smad3,而没有活跃的 TGF-β释放。MyS3KO(髓样细胞特异性 Smad3 敲除)小鼠没有基线缺陷,但表现出晚期死亡率增加和心肌梗死后扩张性重塑加重。MyS3KO 感染小鼠的不良后果与吞噬活性的改变、巨噬细胞向抗炎表型的转变缺陷、疤痕扩张以及边缘区心肌细胞凋亡加剧有关。在体外,Smad3 缺失的巨噬细胞表现出与吞噬作用相关的基因表达减少,如 Mfge8(乳脂肪球表皮生长因子因子 8),并且产生抗炎介质 IL(白细胞介素)-10 和 TGF-β1 的能力降低,以及血管生成生长因子 VEGF(血管内皮生长因子)减少。Mfge8 部分挽救了 Smad3 缺失的巨噬细胞的吞噬缺陷,而不影响炎症活性。Smad3 缺失的巨噬细胞抗炎作用减弱与吞噬作用诱导的 PPAR(过氧化物酶体增殖物激活受体)表达明显减弱有关。MyS3KO 小鼠在重塑心肌节段的微血管密度和间质纤维化中没有明显改变。
我们证明 Smad3 通过介导吞噬表型的获得并有助于抗炎转化来严格调节梗死巨噬细胞的功能。巨噬细胞中的 Smad3 依赖性作用可保护梗死心脏免受不良重塑。